当研究室は2021年度に発足しました。2021年度からの論文を掲載いたします。
2022年度
1 Nakajima R, Matsuo T, Sumiyoshi R, Saito S, Yamamoto T, Matsumoto K, Akiyama N, Ooi J, Ota Y, Shirafuji N, Tashiro H. Extramedullary blast crisis in a chronic myeloid leukaemia patient after achieving a major molecular response with bosutinib. Br J Haematol. 2022 Jan;196(1):e9-e11. doi: 10.1111/bjh.17771. Epub 2021 Aug 10. PMID: 34378212.
2 Sumiyoshi R, Tashiro H, Shirasaki R, Matsuo T, Yamamoto T, Matsumoto K, Ooi J, Shirafuji N. The FLT3 internal tandem duplication mutation at disease diagnosis is a negative prognostic factor in myelodysplastic syndrome patients. Leuk Res. 2022 Feb;113:106790. doi: 10.1016/j.leukres.2022.106790. Epub 2022 Jan 11. PMID: 35092883.
3 Akitomi Y, Asaoka Y, Miura R, Murata S, Yamamoto T, Tashiro H, Shirafuji N, Yamada K, Yamamoto M, Kondo H, Tanaka A. Budd-Chiari Syndrome during Long-term Follow-up after Allogeneic Umbilical Cord Blood Transplantation. Intern Med. 2022 May 15;61(10):1519-1524. doi: 10.2169/internalmedicine.8226-21. Epub 2021 Oct 26. PMID: 34707047; PMCID: PMC9177373.
4 Matsuo T, Tashiro H, Shirasaki R, Sumiyoshi R, Yamamoto T, Saito S, Matsumoto K, Ooi J, Shirafuji N. Serum high-density lipoprotein cholesterol level has a significant prognostic impact on outcomes of follicular lymphoma patients. Medicine (Baltimore). 2022 Jul 29;101(30):e29541. doi: 10.1097/MD.0000000000029541. PMID: 35905283; PMCID: PMC9333492.
5 Kurosawa S, Yamaguchi T, Mori A, Matsuura T, Masuko M, Murata M, Tashiro H, Kako S, Satake A, Hagihara M, Ota S, Saito T, Kagawa K, Matsuo Y, Itonaga H, Uoshima N, Yamaguchi H, Naito K, Takahashi M, Fukuda T. Incidence and predictors of recurrent sick leave in survivors who returned to work after allogeneic hematopoietic cell transplantation. J Cancer Surviv. 2022 Sep 1. doi: 10.1007/s11764-022-01250-8. Epub ahead of print. PMID: 36048313.
6 Yanada M, Matsuda K, Ishii H, Fukuda T, Ozeki K, Ota S, Tashiro H, Uchida N, Kako S, Doki N, Kawakita T, Onishi Y, Takada S, Kondo Y, Tanaka J, Kanda Y, Atsuta Y, Yano S. Allogeneic hematopoietic cell transplantation for patients with relapsed acute promyelocytic leukemia. Transplant Cell Ther. 2022 Sep 27:S2666-6367(22)01659-1. doi: 10.1016/j.jtct.2022.09.021. Epub ahead of print. PMID: 36179987.